ES2119751T3 - Derivados del cromano. - Google Patents

Derivados del cromano.

Info

Publication number
ES2119751T3
ES2119751T3 ES91120050T ES91120050T ES2119751T3 ES 2119751 T3 ES2119751 T3 ES 2119751T3 ES 91120050 T ES91120050 T ES 91120050T ES 91120050 T ES91120050 T ES 91120050T ES 2119751 T3 ES2119751 T3 ES 2119751T3
Authority
ES
Spain
Prior art keywords
derivatives
chroman
alopecia
incontinence
prophylaxis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91120050T
Other languages
English (en)
Inventor
Rolf Dr Gericke
Manfred Dr Baumgarth
Ingeborg Dr Lues
Jurgen Dr Harting
Rolf Dr Bergmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Application granted granted Critical
Publication of ES2119751T3 publication Critical patent/ES2119751T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION CONCIERNE A NUEVOS DERIVADOS DEL CROMANO DE FORMULA I: EN DONDE R ELEVADO 1, R (AL CUADRADO) , R ELEVADO 3, R ELEVADO 4, R ELEVADO 5, R ELEVADO 6, R ELEVADO 7, R ELEVADO 8 Y R ELEVADO 9 TIENEN EL SIGNIFICADO DADO EN LA REIVINDICACION 1 DE LA PATENTE, Y A LOS EFECTOS QUE PRESENTAN, ASI COMO SUS SALES, SOBRE EL SISTEMA CARDIOVASCULAR, PUDIENDO SER UTILIZADOS PARA EL TRATAMIENTO O PROFILAXIS DE LA INSUFICIENCIA CARDIACA, ANGINA PECTORIS, HIPERTENSION SANGUINEA, INCONTINENCIA Y ALOPECIA.
ES91120050T 1990-12-05 1991-11-25 Derivados del cromano. Expired - Lifetime ES2119751T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4038752A DE4038752A1 (de) 1990-12-05 1990-12-05 Chromanderivate

Publications (1)

Publication Number Publication Date
ES2119751T3 true ES2119751T3 (es) 1998-10-16

Family

ID=6419627

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91120050T Expired - Lifetime ES2119751T3 (es) 1990-12-05 1991-11-25 Derivados del cromano.

Country Status (18)

Country Link
US (1) US5238937A (es)
EP (1) EP0489327B1 (es)
JP (1) JPH04300880A (es)
KR (1) KR100220002B1 (es)
AT (1) ATE166649T1 (es)
AU (1) AU645373B2 (es)
CA (1) CA2056845A1 (es)
CZ (1) CZ280911B6 (es)
DE (2) DE4038752A1 (es)
DK (1) DK0489327T3 (es)
ES (1) ES2119751T3 (es)
GR (1) GR3027561T3 (es)
HU (1) HU215518B (es)
IE (1) IE914213A1 (es)
PT (1) PT99688B (es)
SK (1) SK279095B6 (es)
TW (1) TW209863B (es)
ZA (1) ZA919573B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387587A (en) * 1986-12-23 1995-02-07 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
US5837702A (en) * 1993-10-07 1998-11-17 Bristol-Myers Squibb Co. 4-arylamino-benzopyran and related compounds
CA2153498A1 (en) 1993-11-10 1995-05-18 Hidetsura Cho Chroman derivative and medicinal use thereof
US5612323A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phosphinic ester substituted benzopyran derivatives
US5612370A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phenylglycine and phenylalaninen amido benzopyran derivatives
US5629429A (en) * 1995-06-07 1997-05-13 Bristol-Myers Squibb Company Process for preparing 4-arylamino-benzopyran and related compounds
US5869478A (en) * 1995-06-07 1999-02-09 Bristol-Myers Squibb Company Sulfonamido substituted benzopyran derivatives
KR20070003349A (ko) * 2005-07-01 2007-01-05 한 성 육 가설 철도교용 체결장치
US7812183B2 (en) 2005-09-01 2010-10-12 Janssen Pharmaceutica Nv Benzopyran derivatives as potassium channel openers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3835011A1 (de) * 1988-10-14 1990-04-19 Merck Patent Gmbh Chromanderivate
FR2615191B1 (fr) * 1987-05-16 1991-01-11 Sandoz Sa Nouveaux benzo(b)pyrannes et pyrannopyridines, leur preparation et leur utilisation comme medicaments
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives

Also Published As

Publication number Publication date
DE59108997D1 (de) 1998-07-02
HU913797D0 (en) 1992-02-28
DK0489327T3 (da) 1999-03-22
CA2056845A1 (en) 1992-06-06
ATE166649T1 (de) 1998-06-15
HUT62000A (en) 1993-03-29
EP0489327B1 (de) 1998-05-27
KR920012073A (ko) 1992-07-25
PT99688A (pt) 1992-10-30
IE914213A1 (en) 1992-06-17
AU8831391A (en) 1992-06-11
CS367491A3 (en) 1992-06-17
ZA919573B (en) 1992-08-26
PT99688B (pt) 1999-05-31
GR3027561T3 (en) 1998-11-30
EP0489327A1 (de) 1992-06-10
AU645373B2 (en) 1994-01-13
JPH04300880A (ja) 1992-10-23
CZ280911B6 (cs) 1996-05-15
US5238937A (en) 1993-08-24
SK279095B6 (sk) 1998-06-03
HU215518B (hu) 1999-01-28
TW209863B (es) 1993-07-21
DE4038752A1 (de) 1992-06-11
KR100220002B1 (ko) 1999-09-01

Similar Documents

Publication Publication Date Title
ES2148156T3 (es) Imidazopiridinas.
HU9201329D0 (en) The use of sulphonamides for medical purpose and process for the production of new sulphonamides
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
TW221445B (es)
DE59010435D1 (de) Indolocarbazol-Derivate, Verfahren zu deren Herstellung und deren Verwendung
ES2119751T3 (es) Derivados del cromano.
NO971625L (no) Nye peptider med immunomodulatoriske effekter
DK578485A (da) Dihydropyridin-carboxylsyreamider, deres fremstilling og anvendelse i laegemidler
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
SE8704979D0 (sv) New furanuronic acid derivatives, process for their production and their use
SE7811455L (sv) 2-imino-imidazolidin-derivat
DK0660822T3 (da) Cykliske benzylamino-, benzylamido- og benzylimidoderivater som antipsykotiske midler
DK23887D0 (da) Benzimidazolderivater
ES2101738T3 (es) Tintes de benzoxacina.
KR950700896A (ko) 신규의 심장 보호제(Novel Cardioprotective Agents)
IT1241927B (it) 3'-deamino-4'-deossi-4'-amino-8-fluoroantra- cicline processi per la loro preparazione e composizioni farmaceutiche che le contengono
ATE104663T1 (de) Picolylselenobenzamide von aminopyridinen, anilinen und picolylaminen.
TR199701299A2 (xx) Vinilpirrolidon sefalasporin türevleri.
ITMI920878A1 (it) Composizioni farmaceutiche comprendenti derivati monosialogangliosidici atte al trattamento del danno al midollo spinale.
ES2016857B3 (es) Derivados de 4 - feniltiazol.
FI943730A (fi) Menetelmä angiotensiini-II-antagonistina aktiivisen 3-(2'-N-bentsoyylisulfonamido-bifen-4-yyli)metyyli-5,7-dimetyyli-2-etyyli-3H-imidatso/4,5-b/pyridiinin valmistamiseksi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 489327

Country of ref document: ES